BRAF and dermatophytosis: The predisposing factors include chronic untreated dermatophytosis, impaired skin barrier secondary to trauma, animal exposure, immunocompromised patients, long-term use of steroids, chemotherapeutic drugs, use of adalimumab in organ transplantation patients, and BRAF inhibitors (vemurafenib) [6].